Clinical Trial

Genetic Characterization of Patients With Arrhythmia-Induced Cardiomyopathy

Study acronym: UNCHAINED-I
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 14, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to learn about the genetic insights of arrhythmya-induced cardiomyopathy and its clinical prognosis. The main questions it aims to answer are: I. Does patients with arrhythmia-induced cardiomyopathy have a greater proportion of genetic mutations compared with other types of cardiomyopathy or general population? II. Have the genetics any prognostic impact in patients with arrhythmia-induced cardiomyopathy?
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-19; most recent amendment 2025-05-09.
Trial Details
NCT Number NCT06896266
Lead Sponsor Hospital Universitario 12 de Octubre
Conditions Arrhythmia, Cardiomyopathy, Arrhythmia-induced Cardiomyopathy (AiCM)
Enrollment 109 participants
Start Date 2024-12-01
Primary Completion 2025-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-05-14